FDA Inspection
REGI US INCREGI US INC – FDA Inspection, Jan 22, 2025
Record Details
This FDA Inspection record concerns REGI US INC, with an inspection on January 22, 2025, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · 7cd8d1b0-3a67-4e90-8a6a-db16b6f64454
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1260740
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.84(d)(2)Establish reliability of supplier"s C of A
- 21 CFR 211.180(e)Records reviewed annually
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.84(d)(2)Establish reliability of supplier's C of A
Full citation text and observation details available on the Dashboard.
Other FDA inspections of REGI US INC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 15, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for REGI US INC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.